DEALSRedHill Biopharma Pays $12M for Rebyota and Clenpiq Rights, but Royalties Cloud the ReturnsWORLDWarsh set to defy the White House on rates at Wednesday's Fed meetingWORLDVance turns convention floor protest into America First keynote moment in DallasWORLDNike shareholders reject Inspire Investing's transparency push as S&P 100 exit loomsREGULATORYKestra Medical Technologies posts 94.53% shareholder turnout, but Cohen draws more opposition than board peersENERGYRoy Cooper's big-tent calculation raises the stakes in North Carolina's Senate raceDEALSRedHill Biopharma Pays $12M for Rebyota and Clenpiq Rights, but Royalties Cloud the ReturnsWORLDWarsh set to defy the White House on rates at Wednesday's Fed meetingWORLDVance turns convention floor protest into America First keynote moment in DallasWORLDNike shareholders reject Inspire Investing's transparency push as S&P 100 exit loomsREGULATORYKestra Medical Technologies posts 94.53% shareholder turnout, but Cohen draws more opposition than board peersENERGYRoy Cooper's big-tent calculation raises the stakes in North Carolina's Senate race